Om Dhingra

Om Dhingra has over 20 years of experience in the pharmaceutical industry. Om started their career in 2001 as the Head of Preclinical Drug Discovery at GlaxoSmithKline. In 2009, they founded and became the CEO of SOV Therapeutics. In 2017, they co-founded Marius Pharmaceuticals and held the role of Co-Founder and Vice-Chair, as well as Co-founder and Chief Executive Officer.

Om Dhingra obtained a Doctor of Philosophy (Ph.D.) in Organic Chemistry from the University of Virginia.